{"id":13042,"date":"2018-05-24T14:16:50","date_gmt":"2018-05-24T12:16:50","guid":{"rendered":"https:\/\/news.embl.de\/?p=13042"},"modified":"2024-03-22T23:19:37","modified_gmt":"2024-03-22T22:19:37","slug":"phd-start-a-company","status":"publish","type":"post","link":"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/","title":{"rendered":"PhD goals: why not start a company?"},"content":{"rendered":"\n<p>Daniel is in the third year of his PhD degree at EMBL-EBI, in the <a href=\"https:\/\/www.ebi.ac.uk\/research\/thornton\">Thornton Group<\/a>, but unlike other PhD students, he is also starting a company. We caught up with Daniel to find out more.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Tell us about your start-up<\/strong><\/h3>\n\n\n\n<p>It all started with a conversation I had with co-founder Thomas Stubbs, who was doing his PhD in Wolf Reik\u2019s group at the Babraham Institute. We had been working on the epigenetics of ageing for a while. We wanted to explore how we can use epigenetic data to predict certain things people care about \u2013 diet, exercise, stress, air pollution etc. One day, I got contacted on LinkedIn by someone at <a href=\"https:\/\/rebelbio.co\/\">RebelBio<\/a>, the world\u2019s first business accelerator for the life sciences. RebelBio offers seed funding, lab space, mentorship, and other helpful support for starting your own business.<\/p>\n\n\n\n<p>Tom and I thought it was a great opportunity and we went ahead with it. We joined forces with the other co-founders, Toby Call (PhD in Industrial Biotechnology from Cambridge) and Charles Ball (expert in marketing and sales) \u2013 that\u2019s how our company, <a href=\"https:\/\/www.chronomics.co.uk\/?utm_source=EBI&amp;utm_medium=News%20Article&amp;utm_campaign=EMBI%20Brand%20Awareness\">Chronomics<\/a>, was born.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>What are the steps for setting up a business?<\/strong><\/h3>\n\n\n\n<p>It was quite challenging, especially because of the timeline. Of course, we had an idea, but there was a lot of work to do before we could turn that into an actual company. RebelBio interviewed us and they liked our vision. Within ten days, we had secured $100k investment in our idea!<\/p>\n\n\n\n<blockquote class=\"vf-blockquote\"><p>Within ten days, we had secured $100k investment in our idea!<\/p><\/blockquote>\n\n\n\n<p>That\u2019s when things got real. We had one week to sign all the legal documents, tell our supervisors and consider a move to London. In an almost serendipitous way, everything came together and we incorporated the company. The support of Janet Thornton, my supervisor, was a crucial step in the process and I am incredibly thankful to her.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>What kind of product or service will you offer?<\/strong><\/h3>\n\n\n\n<p>Epigenetics is a big deal within the research community, but there is huge potential to transfer its value to society. We want to use epigenetic data to monitor wellbeing and health over time and help people improve their lifestyles. A personalised, preventive and proactive paradigm of health.<\/p>\n\n\n\n<blockquote class=\"vf-blockquote\"><p>We want to use epigenetic data to monitor wellbeing and health over time and help people improve their lifestyles<\/p><\/blockquote>\n\n\n\n<p>The papers bombard us with all this health advice, like eat more fruit and veg, exercise more, quit smoking, do yoga etc. Some of it feels a bit random and evidence-based recommendations are urgently needed. Using DNA methylation data, we want to measure the effect of lifestyle changes at the molecular level.<\/p>\n\n\n\n<p>We send people a saliva collection kit, sequence the sample, process the information and give them access to their results through our secure online platform.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Who is the service aimed at?<\/strong><\/h3>\n\n\n\n<p>Elite athletes, tech enthusiasts or people who are keen to monitor their health are likely to be the early adopters. We\u2019re also targeting organisations, because many employers offer certain tests as part of their health package. These include eyesight, blood, cholesterol tests, so they might be interested in incorporating epigenetics as well.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>How has your work at EMBL-EBI supported your ability to make this leap?<\/strong><\/h3>\n\n\n\n<p>In my PhD, I am trying to understand the biological mechanisms behind the <a href=\"https:\/\/news.embl.de\/science\/1704_mouse-epigenetic-clock\/\">epigenetic clock<\/a>, which is a predictor of biological ageing that uses DNA methylation. I also had the opportunity to work with Tom and Wolf from the very beginning and this was a great fit from a personal and scientific point of view. I\u2019ve been exposed to an amazing community of researchers here, both on the computational side at EMBL-EBI and the wet-lab side at the Babraham.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>It seems like you\u2019re at a time of great change \u2013 what next?<\/strong><\/h3>\n\n\n\n<p>We want to put everything we have into this. We just finished our time at the accelerator and it has been a roller-coaster experience. A lot of pressure but also a lot of fun and the opportunity to meet incredible people. We are currently starting our next funding round and several venture capital firms have already shown interest.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Would you recommend this experience to others?<\/strong><\/h3>\n\n\n\n<p>Absolutely, yeah! If you have ideas you want explore as an entrepreneur, you should definitely try it. You can do great science <em>and<\/em> be an entrepreneur at the same time. Entrepreneurship gives you more freedom in how you push things forward and teaches you a lot of things that are also useful in academia. In the end, I\u2019m still doing what I love \u2013 great science, learning new things and meeting people.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>EMBL-EBI PhD student launches start-up focusing on epigenetics and wellbeing<\/p>\n","protected":false},"author":47,"featured_media":13502,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3,17593],"tags":[28,36,39,71,75,366],"embl_taxonomy":[],"class_list":["post-13042","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lab-matters","category-people-perspectives","tag-bioinformatics","tag-embl-ebi","tag-epigenetics","tag-industry","tag-phd","tag-wellcome-genome-campus"],"acf":{"article_intro":"<p>Daniel Elias Martin Herranz, a PhD student at EMBL-EBI, is launching a company that uses epigenetics to improve people\u2019s wellbeing and health<\/p>\n","related_links":[{"link_description":"A race against the ageing clock","link_url":"https:\/\/news.embl.de\/science\/1704_mouse-epigenetic-clock\/"},{"link_description":"Janet Thornton research group","link_url":"https:\/\/www.ebi.ac.uk\/research\/thornton"}],"article_sources":false,"vf_locked":false,"featured":false,"color":"#007B53"},"embl_taxonomy_terms":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PhD goals: why not start a company? | EMBL<\/title>\n<meta name=\"description\" content=\"EMBL-EBI PhD student, Daniel Elias Martin Herranz starts a company that uses epigenetics to understand health and wellbeing\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PhD goals: why not start a company? | EMBL\" \/>\n<meta property=\"og:description\" content=\"EMBL-EBI PhD student, Daniel Elias Martin Herranz starts a company that uses epigenetics to understand health and wellbeing\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-05-24T12:16:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-22T22:19:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/05\/HERRANZ_Daniel_Elias_Martin_22Jan2018_DarwinBeagle_EMBL_620x425-e1527156927460.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"620\" \/>\n\t<meta property=\"og:image:height\" content=\"425\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Oana Stroe\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@embl\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Oana Stroe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/\"},\"author\":{\"name\":\"Oana Stroe\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/95d28f359cc138357c5dcf79319ef414\"},\"headline\":\"PhD goals: why not start a company?\",\"datePublished\":\"2018-05-24T12:16:50+00:00\",\"dateModified\":\"2024-03-22T22:19:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/\"},\"wordCount\":777,\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/05\/HERRANZ_Daniel_Elias_Martin_22Jan2018_DarwinBeagle_EMBL_620x425-e1527156927460.jpg\",\"keywords\":[\"bioinformatics\",\"embl-ebi\",\"epigenetics\",\"industry\",\"phd\",\"wellcome genome campus\"],\"articleSection\":[\"Lab Matters\",\"People &amp; Perspectives\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/\",\"url\":\"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/\",\"name\":\"PhD goals: why not start a company? | EMBL\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/05\/HERRANZ_Daniel_Elias_Martin_22Jan2018_DarwinBeagle_EMBL_620x425-e1527156927460.jpg\",\"datePublished\":\"2018-05-24T12:16:50+00:00\",\"dateModified\":\"2024-03-22T22:19:37+00:00\",\"description\":\"EMBL-EBI PhD student, Daniel Elias Martin Herranz starts a company that uses epigenetics to understand health and wellbeing\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/#primaryimage\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/05\/HERRANZ_Daniel_Elias_Martin_22Jan2018_DarwinBeagle_EMBL_620x425-e1527156927460.jpg\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/05\/HERRANZ_Daniel_Elias_Martin_22Jan2018_DarwinBeagle_EMBL_620x425-e1527156927460.jpg\",\"width\":620,\"height\":425,\"caption\":\"Daniel Elias Martin Herranz, PhD student at EMB-EBI and entrepreneur. IMAGE: Mary Todd-Bergman\/EMBL-EBI\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.embl.org\/news\/#website\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.embl.org\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.embl.org\/news\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/embl.org\/\",\"https:\/\/x.com\/embl\",\"https:\/\/www.instagram.com\/embl_org\/\",\"https:\/\/www.linkedin.com\/company\/15813\/\",\"https:\/\/www.youtube.com\/user\/emblmedia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/95d28f359cc138357c5dcf79319ef414\",\"name\":\"Oana Stroe\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/105fb83bbeaf64062ef1f4608964e5163ac52f590628df2ffde6de9a0d85af80?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/105fb83bbeaf64062ef1f4608964e5163ac52f590628df2ffde6de9a0d85af80?s=96&d=mm&r=g\",\"caption\":\"Oana Stroe\"},\"description\":\"Oana Stroe is a PR specialist and copywriter with experience in engineering, IT and life sciences. She now collects and shares remarkable science stories.\",\"url\":\"https:\/\/www.embl.org\/news\/author\/oana-stroe-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-3\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PhD goals: why not start a company? | EMBL","description":"EMBL-EBI PhD student, Daniel Elias Martin Herranz starts a company that uses epigenetics to understand health and wellbeing","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/","og_locale":"en_US","og_type":"article","og_title":"PhD goals: why not start a company? | EMBL","og_description":"EMBL-EBI PhD student, Daniel Elias Martin Herranz starts a company that uses epigenetics to understand health and wellbeing","og_url":"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","article_published_time":"2018-05-24T12:16:50+00:00","article_modified_time":"2024-03-22T22:19:37+00:00","og_image":[{"width":620,"height":425,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/05\/HERRANZ_Daniel_Elias_Martin_22Jan2018_DarwinBeagle_EMBL_620x425-e1527156927460.jpg","type":"image\/jpeg"}],"author":"Oana Stroe","twitter_card":"summary_large_image","twitter_creator":"@embl","twitter_site":"@embl","twitter_misc":{"Written by":"Oana Stroe","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/#article","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/"},"author":{"name":"Oana Stroe","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/95d28f359cc138357c5dcf79319ef414"},"headline":"PhD goals: why not start a company?","datePublished":"2018-05-24T12:16:50+00:00","dateModified":"2024-03-22T22:19:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/"},"wordCount":777,"publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"image":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/05\/HERRANZ_Daniel_Elias_Martin_22Jan2018_DarwinBeagle_EMBL_620x425-e1527156927460.jpg","keywords":["bioinformatics","embl-ebi","epigenetics","industry","phd","wellcome genome campus"],"articleSection":["Lab Matters","People &amp; Perspectives"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/","url":"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/","name":"PhD goals: why not start a company? | EMBL","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/#primaryimage"},"image":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/05\/HERRANZ_Daniel_Elias_Martin_22Jan2018_DarwinBeagle_EMBL_620x425-e1527156927460.jpg","datePublished":"2018-05-24T12:16:50+00:00","dateModified":"2024-03-22T22:19:37+00:00","description":"EMBL-EBI PhD student, Daniel Elias Martin Herranz starts a company that uses epigenetics to understand health and wellbeing","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/lab-matters\/phd-start-a-company\/#primaryimage","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/05\/HERRANZ_Daniel_Elias_Martin_22Jan2018_DarwinBeagle_EMBL_620x425-e1527156927460.jpg","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/05\/HERRANZ_Daniel_Elias_Martin_22Jan2018_DarwinBeagle_EMBL_620x425-e1527156927460.jpg","width":620,"height":425,"caption":"Daniel Elias Martin Herranz, PhD student at EMB-EBI and entrepreneur. IMAGE: Mary Todd-Bergman\/EMBL-EBI"},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]},{"@type":"Person","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/95d28f359cc138357c5dcf79319ef414","name":"Oana Stroe","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/105fb83bbeaf64062ef1f4608964e5163ac52f590628df2ffde6de9a0d85af80?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/105fb83bbeaf64062ef1f4608964e5163ac52f590628df2ffde6de9a0d85af80?s=96&d=mm&r=g","caption":"Oana Stroe"},"description":"Oana Stroe is a PR specialist and copywriter with experience in engineering, IT and life sciences. She now collects and shares remarkable science stories.","url":"https:\/\/www.embl.org\/news\/author\/oana-stroe-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-3\/"}]}},"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"fimg_url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/05\/HERRANZ_Daniel_Elias_Martin_22Jan2018_DarwinBeagle_EMBL_620x425-e1527156927460.jpg","featured_image_src":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/05\/HERRANZ_Daniel_Elias_Martin_22Jan2018_DarwinBeagle_EMBL_620x425-e1527156927460.jpg","_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/13042","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/users\/47"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/comments?post=13042"}],"version-history":[{"count":9,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/13042\/revisions"}],"predecessor-version":[{"id":21881,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/13042\/revisions\/21881"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media\/13502"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=13042"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/categories?post=13042"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/tags?post=13042"},{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/embl_taxonomy?post=13042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}